A plant genome engineering platform using engineered CRISPR-Cas9 fused to viral 5'-exonucleases to dramatically increase homology-directed repair, enabling precise chromosomal inversions via supplied donor templates. Achieves up to 30-fold higher HDR frequency compared to non-engineered Cas9.
This technology leverages engineered CRISPR-Cas9 nucleases fused to viral 5'-exonucleases to enable precise chromosomal inversions in plants. By introducing double-strand breaks at each end of a target chromosomal fragment and supplying short donor templates with homology arms matching the desired inverted outcome, the platform dramatically increases the frequency of homology-directed repair (HDR). This addresses a major bottleneck in plant genome engineering, where HDR is naturally rare, and opens new possibilities for synthetic chromosome restructuring, gene regulatory studies, and crop improvement.
Key features:
The core HDR-enhancing Cas9-exonuclease fusion technology has been validated in transient and stable plant transformation experiments, with results available in a preprint. Preliminary work on intron-enhanced Cas9 expression has been published. The chromosomal inversion application is at an advanced research and proof-of-concept stage, with planned validation including sgRNA efficiency screening via amplicon sequencing, PCR-based identification of inversion events among approximately 100-200 transformants, and segregation of T-DNA constructs in subsequent generations. The technology is ready for collaborative validation and pilot applications in partner-relevant plant species.
The Leibniz Institute of Plant Biochemistry (IPB) is a non‑university research institute in Halle (Saale), Germany, located on the Weinberg Campus technology park with extensive shared laboratories and research infrastructure. Industry partners access co‑located analytical and imaging platforms—metabolomics, MS/NMR, advanced microscopy—supported by greenhouses, phytochambers, and a small test field. Close ties and joint appointments with Martin Luther University Halle‑Wittenberg connect companies to talent and collaborative research. Work is backed by competitive German federal and EU programs, and a patents‑and‑licensing function publishes technology offers to enable commercialization.